Risks and benefits with Professor Fenton
December 12, 2022
400,208
10,992
2,175
3.29%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Campbell Episodes Around December 12, 2022
See what was published immediately before and after this episode.
56:27Now PlayingRisks and benefits with Professor Fenton
Segments
YouTube Description
as posted by the channelRelative risk versus absolute risk with Professor Norman Fenton, Mathematician, Professor of Risk Information Management
Professor Fenton, YouTube channel
And Sub stack
normanfenton.com
Link to video on Norman's channel
Download the slides used in this video
Nor
What is risk information management?
Thinking about risk, what do we mean by absolute risk and relative risk
Sounds a bit like the level of risk can be presented in a way that gives a particular impression of a greater or a lessor risk or benefit?
Are there occasions when a vested interest might want to give an impression of an increased benefit, or reduced risk from an intervention?
How could choosing RRR versus ARR influence the impression given for adverse reactions is medical journals?
Conversely
Are there occasions when a vested interest might want to give an impression of a decreased risk from an intervention?
So will RRR always be higher than ARR?
Why can the RRR vary between populations and vary over time?
So using one of the two measures to estimate the risk/benefit ratio would lead to different conclusions?
How could risk / benefit reporting be optimised in the medical literature?
Do you think the editors of prestigious international journals are aware of the differences between RRR and ARR?
In the case of this paper from the Journal of Expert Reviews of Vaccines
Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction
The original phase three data gave an efficacy for Pfizer vaccine, at preventing infection with SARS-CoV-2 of 95%, but it turns out the ARR was 0.84%
Why are these figures so different?
So is it fair to say that the ‘real world translation’ of the ARR of the Pfizer vaccine over 5 to 6 months of use increased to 3.7%?
What do we mean by number needed to treat?
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.